Skip to main content
. Author manuscript; available in PMC: 2023 Sep 1.
Published in final edited form as: Shock. 2022 Aug 8;58(3):217–223. doi: 10.1097/SHK.0000000000001972

TABLE 3A.

Trauma patients (n = 46)—thrombin generation kinetics, cfDNA, and histone levels (+/−DNAse) for trauma patients (n = 46) with and without the addition of DNAse I (1,000 U/mL)

(−) DNAse (+) DNAse Median difference Median % change P
LT (min) 3.11
[2.67, 3.52]
2.93
[2.67, 3.19]
−0.21 −5.9 < 0.001
PH (nM) 273.7
[230.7, 300.5]
288.7
[257.6, 319.2]
20.7 7.9 < 0.001
ttPeak (min) 6.00
[5.33, 6.67]
5.48
[5.00, 6.00]
−0.55 −8.6 < 0.001
cfDNA (ng/mL) 576.9
[503.3, 803.1]
456.0
[393.5, 626.7]
−133.4 −22.3 < 0.001
CitH3 (ng/mL) 4.54
[2.23, 10.01]
3.59
[1.93, 7.98]
−0.65 −14.4 < 0.001
H4 (ng/mL) 1.30
[0.64, 6.36]
1.75
[0.83, 9.67]
0.44 32.8 < 0.001

LT, lag time; PH, peak height; ttPeak, time to peak; CitH3, citrullinated histone 3; H4, histone 4.

All values expressed as median and quartiles [Q1, Q3]. Wilcoxon rank-sum (unpaired) testing.

Significant P values (P < 0.05) appear in bold.